Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
396 results
  • Revisiting the Pharmacodynamic Uroselectivity of α 1-Adrenergic Receptor Antagonists. [Journal Article]
    J Pharmacol Exp Ther 2019; 371(1):106-112Quaresma BMCS, Pimenta AR, … Noël F
  • α1-Adrenoceptor (AR) antagonists are widely used for the relief of urinary retention secondary to benign prostatic hyperplasia (BPH). While the five Food and Drug Administration-approved α 1-AR antagonists (terazosin, doxazosin, alfuzosin, tamsulosin, and silodosin) share similar efficacy, they differ in tolerability, with reports of ejaculatory dysfunction. The aim of the present work was to rev…
  • [LUTS/BPH who treats?. The results of the epidemiologic study]. [Journal Article]
    Urologiia 2019; (1):5-15Pushkar DY, Rasner PI, … Shormanov IS
  • CONCLUSIONS: the results of the study indicate a concordance with global trends in the treatment of these patients. Our data reflect a significant influence of the level of education, work experience and involvement in scientific professional life of urologic community on the choice of a particular drug for the treatment of LUTS/BPH and prove the feasibility of further work which should be aimed at popularization of the modern medical knowledges among the urologists and organization of a process of continuous medical education.
New Search Next